a wholly owned subsidiary of Fischer Medical Ventures Ltd., for First-in-Class Medical Technology Innovation

 

Collaboration marks a historic first for the WFNS Innovation & Technology Committee, strengthening global neurosurgical innovation through advanced medical imaging and technology partnerships.

 

 

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced a landmark collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India), a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care.

 

 

For the first time in its history, the WFNS Innovation & Technology Committee has formally welcoming an industry partner into its innovation ecosystem, reflecting the growing importance of collaboration between neurosurgical leadership and advanced medical technology providers.

 

 

The World Federation of Neurosurgical Societies Innovation & Technology Committee has entered into a landmark collaboration with Time Medical India to advance global neurosurgical innovation. This marks the first time the Committee has formally partnered with an industry participant. The collaboration will focus on cutting-edge neurosurgical technologies, advanced medical imaging, global training and knowledge-sharing initiatives to improve patient outcomes worldwide. Both organizations aim to set a new benchmark for ethical, innovation-led partnerships in global neurosurgical care.

 

 

The partnership aims to accelerate the development and dissemination of cutting-edge neurosurgical technologies, support global training and capacity building initiatives, and facilitate meaningful collaboration between clinicians and industry innovators to improve patient outcomes worldwide.

 

 

Time Medical International Ventures Pvt. Ltd. has been recognised for its contributions in advanced medical imaging and neurosurgical technologies, including single room intraoperative MRI operation suites, Exoscope and visualisation technologies, and specialised MRI solutions for brain aneurysm and ICAD screening. The association is expected to create a strong platform for innovation driven advancements in neurosurgery and neuroimaging.

 

 

Commenting on the partnership, Prof. Dr. Iype Cherian, Chairperson of the WFNS Innovation & Technology Committee, said:

 

 

“For the first time in the history of the WFNS Innovation Committee, we are opening our doors to the private sector. This partnership reflects our commitment to bringing together the most innovative minds and transformative technologies to advance neurosurgical care globally. Time Medical International Ventures has demonstrated exceptional capabilities in innovation and clinical technology, making them an ideal partner as we work collectively to shape the future of neurosurgery.”

 

 

He further added:

“This collaboration will help champion the development and global dissemination of cutting-edge neurosurgical solutions, facilitate knowledge exchange between leading neurosurgeons and industry experts, and support training and technology transfer initiatives in emerging markets. We believe this partnership will set a new benchmark for industry collaboration within global neurosurgical governance.”

 

 

Speaking on the association, Svetlana Rao, Director of Time Medical International Ventures (India) Pvt. Ltd., said:

“We are honoured to be welcomed as an Industry Partner by the WFNS Innovation & Technology Committee. This collaboration represents a shared vision of advancing neurosurgical excellence through innovation, technology, and global cooperation. As a wholly owned subsidiary of Fischer Medical Ventures Limited, we remain committed to supporting transformative healthcare solutions that improve accessibility, precision, and patient outcomes across diverse healthcare systems.”

 

 

The partnership underscores a shared commitment toward ethical, impactful, and innovation-led progress in neurosurgery and is expected to serve as a model for future global collaborations between clinical leadership and the medical technology industry.

 

 

The WFNS Innovation & Technology Committee expressed confidence that this landmark partnership will set a new benchmark for the role of industry within global neurosurgical governance and serve as a model for future collaborations. The Committee reaffirmed its commitment to ensuring that the engagement remains impactful, transparent, and guided by the highest ethical standards.

 

 

The Committee further stated that it looks forward to welcoming Time Medical International Ventures to the WFNS Innovation & Technology Committee with great enthusiasm and optimism. Together, both organisations aim to shape the future of neurosurgery through shared vision, collaboration, innovation, and an enduring commitment to improving patient outcomes worldwide.